Jin Medical International (ZJYL) Stock Soars Over 17% After-Hours: Here's What's Going On
JIN MEDICAL INTERNATIONAL Says Will Obtain Contractual Control Over, Right To Receive Substantially All Economic Benefits Of, Huaxia Qiying Through VIE Agreements; Co, Erhua Med Will Not Acquire Legal Title To Equity Interests Of Chenglan Kangxu Or Huaxia Qiying Solely As A Result Of VIE Agreements; Agreement Provides For Aggregate Consideration Of $159.4M For Integrated Transaction
Jin Medical International (ZJYL) Stock Soars Over 63% After Hours: Here's What You Need To Know
JIN MEDICAL INTERNATIONAL LTD. Reports First Half of Fiscal Year 2026 Financial Results
Jin Medical International Ltd. Has Regained Compliance with Nasdaq's Minimum Bid Price Requirement
Jin Medical International Regains Nasdaq Compliance
Trading Halt: Halt status updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times
Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending
Reported Earlier, Jin Medical International Approves 1-For-20 Share Combination, Reducing Class A Shares From 136.5M To 6.8M, Effective March 16, 2026 For Nasdaq Compliance
Jin Medical International Ltd. Announces 1-for-20 Share Combination as Part of Strategic Nasdaq Compliance Initiative
Jin Medical CEO Fireside Chat
Jin Medical International Ltd. To Host Management Fireside Chat
Jin Medical International Subsidiary Expects To Start Full Capacity Production At Its Manufacturing Site In Chuzhou, China, By April End
Jin Medical International Ltd. Management Plans For Fireside Chat
12 Health Care Stocks Moving In Wednesday's Intraday Session
12 Health Care Stocks Moving In Wednesday's After-Market Session
12 Health Care Stocks Moving In Friday's Intraday Session
Are Jin Medical International Ltd.'s (NASDAQ:ZJYL) Mixed Financials The Reason For Its Gloomy Performance on The Stock Market?
12 Health Care Stocks Moving In Tuesday's After-Market Session
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.